|
|
|
|
Molecular Pharmacology, Vol 2, 275-283, Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics
-(2-methylhydrazino)-p-toluamide
1 Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut
N-Isopropyl-
-(2-methylhydrazino)-p-toluamide inhibited the incorporation of thymidine-3H, deoxycytidine-3H, formate-14C, adenine-8-14C, and 4-amino-5-imidazolecarboxamide-2-14C into DNA, and the utilization of orotic acid-6-14C and leucine-1-14C for the
synthesis of RNA and protein, respectively, in L5178Y lymphoma cells. The site of the
drug-induced blockade of the formation of DNA did not appear to reside at the level of
thymidine kinase (ATP:thymidine 5'-phosphotransferase, EC 2.7.1.21), thymidine monophosphate kinase (ATP:thymidine monophosphate phosphotransferase, EC 2.7.4.9), or
DNA nucleotidyltransferase (deoxynucleosidetriphosphate:DNA deoxynucleotidyltransferase, EC 2.7.7.7). Furthermore, treatment of cells with N-isopropyl-
-(2-methylhydrazino)-p-toluamide did not influence the rate of loss of thymine-3H from prelabeled DNA.
Possible metabolic alterations which might explain the observed results are discussed.
The inhibitions of the syntheses of nucleic acids and proteins that were measured were
followed by a period during which most of the cell death occurred; this period corresponded with the development of a metabolic imbalance that was characterized by an
accumulation of RNA and protein and an increase in cell volume.
Note:
ACKNOWLEDGMENTS
The authors wish to thank Dr. W. E. Scott,
Hoffmann-La Roche, Inc. for a generous supply
of MIH and Miss Sheila J. Feld for excellent
technical assistance. This investigation was supported by USPHS Research Grant CA-02817 from
the National Cancer Institute and by Grants ACS
IN-31E-806 and ACS IN-31F-905 from the American Cancer Society. One of us (S.T.) gratefully
acknowledges postdoctoral support from the Anna
Fuller Fund.